Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma

Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma

Prevention Program · 1997 · 4.1K citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007

Journal of Allergy and Clinical Immunology · 2007 · 2.2K citations

Medicine, Internal Medicine, Pharmacotherapy +14

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

Helen K. Reddel, D. Robin Taylor, Eric D. Bateman et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 1.9K citations

Medicine, Pediatrics, Pediatric Pulmonology +12

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Exploring the Effects of Omalizumab in Allergic Asthma

Nicola A. Hanania, Sally E. Wenzel, Karin Rosén et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 886 citations

Life Sciences, Immunology, Pharmacotherapy +15